Target intelligence / Profile preview

Lead ion (Pb²⁺)

Target
Pb²⁺
Molecular classification
Other (heavy metal ion)
01

Overview

The lead ion (Pb²⁺) is the predominant bioactive form of lead, a heavy metal with atomic number 82 and high density[1][3][7][9]. It is an environmental toxicant with no known physiological function in humans or other organisms[8]. The cation Pb²⁺ mimics calcium ions, interfering with calcium-dependent cellular processes and homeostasis, and binds to various biomolecules, replacing essential metals in proteins, enzymes, and regulatory cofactors[2][4][6]. Lead exposure disrupts signaling, impairs neurodevelopment, and causes widespread systemic toxicity. Lead enters cells via calcium channels and binds to proteins such as calmodulin, metalloproteins, and enzymes—especially δ-aminolevulinic acid dehydratase (ALAD), contributing to heme synthesis inhibition and anemia as well as neurological symptoms[2][4]. Lead poisoning is managed therapeutically by chelating agents that bind Pb²⁺, facilitating renal excretion[2]. There is no safe level of Pb²⁺ in blood; occupational and environmental exposure is strictly regulated due to severe long-term health risks for all age groups[8]. Lead ion is not a classical drug target but is a major focus in diagnostics, public health, and toxicology.

Other names
Lead(II) ionPlumbous ionPb²⁺
02

Mechanism of action

Chelators bind Pb²⁺, forming complexes to enhance its excretion and reduce tissue binding

03

Biological functions

None (not an endogenous signaling molecule or functional protein)Interferes with normal biological ion regulation
04

Disease associations

NeurotoxicityCardiovascular toxicityDevelopmental toxicityRenal toxicity
05

Safety considerations

Severe systemic toxicity: nervous system damage, cognitive deficits, anemia, nephropathy, hypertensionNo safe exposure level for children or pregnant women
06

Interacting drugs

Chelating agents (such as EDTA, dimercaprol, succimer/DMSA, penicillamine)
07

Biomarkers

Blood lead concentrationUrine lead concentrationδ-Aminolevulinic acid dehydratase (ALAD) activity (inhibited by Pb²⁺)Zinc protoporphyrin (elevated in lead poisoning)

Beyond the preview

Go deeper on Lead ion (Pb²⁺).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lead ion (Pb²⁺).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call